Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6840
pubmed:dateCreated
2001-6-21
pubmed:abstractText
Tissue injury generates endogenous factors that heighten our sense of pain by increasing the response of sensory nerve endings to noxious stimuli. Bradykinin and nerve growth factor (NGF) are two such pro-algesic agents that activate G-protein-coupled (BK2) and tyrosine kinase (TrkA) receptors, respectively, to stimulate phospholipase C (PLC) signalling pathways in primary afferent neurons. How these actions produce sensitization to physical or chemical stimuli has not been elucidated at the molecular level. Here, we show that bradykinin- or NGF-mediated potentiation of thermal sensitivity in vivo requires expression of VR1, a heat-activated ion channel on sensory neurons. Diminution of plasma membrane phosphatidylinositol-4,5-bisphosphate (PtdIns(4,5)P2) levels through antibody sequestration or PLC-mediated hydrolysis mimics the potentiating effects of bradykinin or NGF at the cellular level. Moreover, recruitment of PLC-gamma to TrkA is essential for NGF-mediated potentiation of channel activity, and biochemical studies suggest that VR1 associates with this complex. These studies delineate a biochemical mechanism through which bradykinin and NGF produce hypersensitivity and might explain how the activation of PLC signalling systems regulates other members of the TRP channel family.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0028-0836
pubmed:author
pubmed:issnType
Print
pubmed:day
21
pubmed:volume
411
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
957-62
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:11418861-Animals, pubmed-meshheading:11418861-Bradykinin, pubmed-meshheading:11418861-Cell Line, pubmed-meshheading:11418861-Electrophysiology, pubmed-meshheading:11418861-Enzyme Activation, pubmed-meshheading:11418861-Female, pubmed-meshheading:11418861-Hot Temperature, pubmed-meshheading:11418861-Male, pubmed-meshheading:11418861-Mice, pubmed-meshheading:11418861-Nerve Growth Factor, pubmed-meshheading:11418861-Nociceptors, pubmed-meshheading:11418861-Oocytes, pubmed-meshheading:11418861-Pain, pubmed-meshheading:11418861-Phosphatidylinositol 4,5-Diphosphate, pubmed-meshheading:11418861-Protein Kinase C, pubmed-meshheading:11418861-Receptor, trkA, pubmed-meshheading:11418861-Receptors, Drug, pubmed-meshheading:11418861-Signal Transduction, pubmed-meshheading:11418861-Type C Phospholipases, pubmed-meshheading:11418861-Xenopus laevis
pubmed:year
2001
pubmed:articleTitle
Bradykinin and nerve growth factor release the capsaicin receptor from PtdIns(4,5)P2-mediated inhibition.
pubmed:affiliation
Department of Cellular and Molecular Pharmacology, University of California, San Francisco, California 94143-0450, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, U.S. Gov't, Non-P.H.S., Research Support, Non-U.S. Gov't